NI
65
-2
HCA
64
5
AES
47
-3
MA
55
4
ADM
47
2
UNM
65
-7
TGNA
53
-3
DTE
38
-4
SWKS
55
2
WDC
70
2
FDX
74
3
HRB
46
4
MTB
73
4
AIG
77
2
SE
49
2
A
43
-5
BA
47
4
C
82
3
XYL
33
6
AIZ
78
2
NI
65
-2
HCA
64
5
AES
47
-3
MA
55
4
ADM
47
2
UNM
65
-7
TGNA
53
-3
DTE
38
-4
SWKS
55
2
WDC
70
2
FDX
74
3
HRB
46
4
MTB
73
4
AIG
77
2
SE
49
2
A
43
-5
BA
47
4
C
82
3
XYL
33
6
AIZ
78
2
Financhill
Back

BioNTech SE Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

BNTX
BioNTech SE

Last Price:
$92.52
Seasonality Move:
10.6%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing slight buying pressure.

BioNTech SE Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 93.52 Sell
20-day SMA: 96.07 Sell
50-day SMA: 101.04 Sell
200-day SMA: 102.86 Sell
8-day EMA: 93.35 Sell
20-day EMA: 95.92 Sell
50-day EMA: 99.34 Sell
200-day EMA: 103.39 Sell

BioNTech SE Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.6 Sell
Relative Strength Index (14 RSI): 35.97 Sell
Chaikin Money Flow: 214279 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.53 - 100.73) Sell
Bollinger Bands (100): (97.4 - 108.38) Sell

BioNTech SE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioNTech SE Stock

Is BioNTech SE Stock a Buy?

  • BioNTech SE share price is 92.50 while BNTX 8-day simple moving average is 93.52, which is a Sell signal.
  • The stock price of BNTX is 92.50 while BioNTech SE 20-day SMA is 96.07, which makes it a Sell.
  • BioNTech SE 50-day simple moving average is 101.04 while BNTX share price is 92.50, making it a Sell technically.
  • BNTX stock price is 92.50 and BioNTech SE 200-day simple moving average is 102.86, creating a Sell signal.

BNTX Technical Analysis vs Fundamental Analysis

Sell
25
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $92.50. The Score for BNTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.

BioNTech SE Stock Info

Market Cap:
22.2B
Price in USD:
92.50
Share Volume:
2.7M

BioNTech SE 52-Week Range

52-Week High:
129.27
52-Week Low:
81.20
Sell
25
BioNTech SE (BNTX) is a Sell

BioNTech SE Share Price Forecast

  • What is the BioNTech SE stock price today?
    The BioNTech SE stock price is 92.50 USD today.
  • Will BNTX stock go up or go down?
    BioNTech SE> share price is forecast to RISE/FALL based on technical indicators
  • Is BioNTech SE overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioNTech SE is overvalued.

Is BioNTech SE Stock a Buy?

  • BioNTech SE share price is 92.50 while BNTX 8-day exponential moving average is 93.35, which is a Sell signal.
  • The stock price of BNTX is 92.50 while BioNTech SE 20-day EMA is 95.92, which makes it a Sell.
  • BioNTech SE 50-day exponential moving average is 99.34 while BNTX share price is 92.50, making it a Sell technically.
  • BNTX stock price is 92.50 and BioNTech SE 200-day simple moving average is 103.39, creating a Sell signal.

Fundamental Analysis of BioNTech SE

Is BioNTech SE a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $1.24 per share.

Technical Analysis of BioNTech SE

Should I short BioNTech SE stock?

* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.